Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies

Lorenzo Mortara; Andrew V. Benest; Lisa Derosa; Salem Chouaib; Domenico Ribatti

doi:10.3389/fimmu.2022.1045074

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies

Lorenzo Mortara
, Andrew V. Benest
, Lisa Derosa
, Salem Chouaib
, Domenico Ribatti

Gulf Medical University

University of Insubria
University of Nottingham
Institut national de la santé et de la recherche médicale
University Paris-Saclay
University of Bari

Research output: Contribution to journal › Editorial

5 Scopus citations

Original language	English
Article number	1045074
Journal	Frontiers in Immunology
Volume	13
DOIs	https://doi.org/10.3389/fimmu.2022.1045074
State	Published - 6 Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Cancer
Immunity
immune checkpoint inhibitors
immunotherapies
microbiota
tumor angiogenesis
tumor microenvironment

Access to Document

10.3389/fimmu.2022.1045074

Cite this

Mortara, L., Benest, A. V., Derosa, L., Chouaib, S., & Ribatti, D. (2022). Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies. Frontiers in Immunology, 13, Article 1045074. https://doi.org/10.3389/fimmu.2022.1045074

@article{405cb09863634603aff6dd18e621c66f,

title = "Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies",

keywords = "Cancer, Immunity, immune checkpoint inhibitors, immunotherapies, microbiota, tumor angiogenesis, tumor microenvironment",

author = "Lorenzo Mortara and Benest, \{Andrew V.\} and Lisa Derosa and Salem Chouaib and Domenico Ribatti",

year = "2022",

month = oct,

day = "6",

doi = "10.3389/fimmu.2022.1045074",

language = "English",

volume = "13",

journal = "Frontiers in Immunology",

issn = "1664-3224",

publisher = "Frontiers Media S.A.",

}

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies. / Mortara, Lorenzo; Benest, Andrew V.; Derosa, Lisa et al.
In: Frontiers in Immunology, Vol. 13, 1045074, 06.10.2022.

Research output: Contribution to journal › Editorial

TY - JOUR

T1 - Editorial

T2 - The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies

AU - Mortara, Lorenzo

AU - Benest, Andrew V.

AU - Derosa, Lisa

AU - Chouaib, Salem

AU - Ribatti, Domenico

PY - 2022/10/6

Y1 - 2022/10/6

KW - Cancer

KW - Immunity

KW - immune checkpoint inhibitors

KW - immunotherapies

KW - microbiota

KW - tumor angiogenesis

KW - tumor microenvironment

UR - https://www.scopus.com/pages/publications/85140347388

U2 - 10.3389/fimmu.2022.1045074

DO - 10.3389/fimmu.2022.1045074

M3 - Editorial

C2 - 36275734

AN - SCOPUS:85140347388

SN - 1664-3224

VL - 13

JO - Frontiers in Immunology

JF - Frontiers in Immunology

M1 - 1045074

ER -

Editorial: The intricate innate immune-cancer cell relationship in the context of tumor angiogenesis, immunity and microbiota: The angiogenic switch in the tumor microenvironment as a key target for immunotherapies

UN SDGs

Keywords

Access to Document

Other files and links

Cite this